RP Bio Inc.

Research RP Bio Inc. (314140.KQ) on Bullrun: market cap KRW 47.31B, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 47.31B; dividend yield is 0.9%.

Peer valuation comparison

Latest dividend yield is 0.91% versus a Healthcare sector median of 2.4% (62.1% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 47.31Bn/a0.9%50

Dividend history

Latest trailing dividend snapshot: annual dividend/share 50 KRW, yield 0.9%.

About RP Bio Inc.

RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, antihistamine, and chewable soft capsules; hard capsules; and jelly and powder sticks; Urusa, flagship soft capsule; omega-3 and lutein products, and granule, effervescent granule, and stick type capsule powders. The company also provides cold and liver medicines; vitamins; blood circulation improvers; and pain relievers.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is RP Bio Inc.'s market cap?

RP Bio Inc.'s market capitalization is KRW 47.31B.

Does RP Bio Inc. pay a dividend?

RP Bio Inc. has a dividend yield of 0.9%.

What does RP Bio Inc. do?

RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, antihistamine, and chewable soft capsules; hard capsules; and jelly and powder sticks; Urusa, flagship soft capsule; omega-3 and lutein products, and granule, effervescent granule, and stick type capsule powders. The company also provides cold and liver medicines; vitamins; blood circulation improvers; and pain relievers. The company was founded in 1983 and is headquartered in Seoul, South Korea.